Delivery of a Culturally Tailored Exercise Training Intervention for Hispanics With Multiple Sclerosis
Part of paid clinical trials in Houston, Texas.
- Sponsor
- The University of Texas Health Science Center, Houston
- Study ID
- NCT07606742
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Exercise Training — BEHAVIORALParticipants will then be mailed exercise materials in their preferred language, including the program manual, logbook, calendar, newsletters, Fitbit, and resistance bands, along with instructions for telephone or video conference calls. This is a 16-week, home-based program, supported remotely via Internet-based behavioral coaching, which integrates behavior change techniques based on Social Cognitive Theory (SCT)
Study Details
The purpose of this study is to establish differences in the primary outcome of walking dysfunction using the 12-Item Multiple Sclerosis Walking Scale (MSWS-12) and to establish differences in the secondary outcome of HRQoL using the 29-Item Multiple Sclerosis Walking Scale (MSWS-29) between the exercise training intervention condition and the waitlist control condition following the 16-week intervention period.
Key Dates
- First listed
- May 26, 2026
- Start date
- Sep 1, 2026
- Status verified
- Aug 2026
- Primary completion
- Jun 30, 2028
- Completion
- Oct 31, 2028
Study Design
- Enrollment
- 66 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- SUPPORTIVE_CARE
Arms
- Experimental: Exercise Training
- No Intervention: Waitlist Control
Primary Outcome Measure
Change in walking ability as assessed by the 12-Item Multiple Sclerosis Walking Scale (MSWS-12) [ Time Frame: Baseline, 16 weeks, 32 weeks ]
Central Contacts
- Stephanie L Silveira, PhD(713) 500-9490
- Najha Black713-500-9154
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| The University of Texas Health Science Center at Houston | Houston | Texas | 77030 |
Find similar trials in Houston, TX
By condition
By specialty
Related Studies
- NARCOMS Registry: A Multiple Sclerosis RegistryRecruiting · University of Texas Southwestern Medical Center · Dallas, Texas
- Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVOPHASE1 · Recruiting · National Cancer Institute (NCI) · Sacramento, California
- Non-invasive BCI-controlled Assistive DevicesRecruiting · University of Texas at Austin · Austin, Texas
- Ocrelizumab Discontinuation in Relapsing Multiple SclerosisPHASE4 · Recruiting · National Institute of Allergy and Infectious Diseases (NIAID) · New Haven, Connecticut